A Clinical Study of YTS109 Cells for the Treatment of R/R Autoimmune Diseases

Clinical trial NCT07123519 · RECRUITING

Trial details

NCT number: NCT07123519
Sponsor: China Immunotech (Beijing) Biotechnology Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Systemic Lupus Erythematosus (SLE)Lupus Nephritis (LN)Sjogren's Syndrome (SS)Inflammatory Myopathy Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis Antiphospholipid Syndrome (APS)

Start date: 2025-08-13
Primary completion: 2026-08-13
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.